INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical- stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announces its financial results for the quarter ended June 30, 2025 and provides a business update. Exhibit 99.1 Q2 2025 and Recent Corporate Highlights DN-T ...